Navigation Links
Double mastectomy halves death risk for women with BRCA-related breast cancer
Date:2/12/2014

TORONTO, ON, February 11, 2014 Women with BRCA-related breast cancer who have a double mastectomy are nearly 50 per cent less likely to die of breast cancer within 20 years of diagnosis compared to women who have a single mastectomy, according to a new study led by Women's College Hospital's Kelly Metcalfe.

The findings, published in the British Medical Journal, suggest a double mastectomy may be an effective first-line treatment for women with early-stage breast cancer who carry a BRCA1 or BRCA2 genetic mutation. The BRCA1/2 genes belong to a class of genes that typically act to protect individuals from acquiring cancer, yet women who inherit a mutated form of the genes have a high risk of developing breast and ovarian cancers.

"Women with a BRCA mutation have a 60 to 70 per cent chance of developing breast cancer in their lifetime, and once diagnosed, a further 34 per cent chance of developing breast cancer in the opposite breast within 15 years," said Kelly Metcalfe, an adjunct scientist at Women's College Research Institute and professor at the University of Toronto. "For these women, we need to think about treating the first breast cancer, but also about preventing a second breast cancer."

To compare the survival rates of women with BRCA-related breast cancers, researchers assessed the medical records of 390 women with stage one or two breast cancer and a BRCA1 or BRCA2 mutation. The women were required to have been initially treated with a single or double mastectomy. The researchers found:

  • Women who had a double mastectomy had a 48% greater likelihood of surviving compared to women with a single mastectomy
  • For women who developed a new breast cancer in the opposite breast, the risk of dying of breast cancer was doubled
  • At twenty years, the survival rate was 88% for women with a double mastectomy and 66% for women with a single mastectomy

"Our study's results provide evidence that in order to improve survival in women with BRCA-associated breast cancer, we need to prevent new breast cancers from developing after an initial diagnosis," said Dr. Steven Narod, a co-author of the study and a senior scientist at Women's College Research Institute. "This study highlights the importance of providing genetic testing for BRCA1 and BRCA2 at the time of breast cancer diagnosis if appropriate. This genetic information could help women make decisions that ultimately may increase their chance of surviving breast cancer."

Last year, Hollywood actress Angelina Jolie, publicly announced her decision to opt for a double mastectomy and breast reconstruction surgery after discovering she had the BRCA1 gene. The then 37 year-old actress said doctors estimated she had a 50 per cent risk of developing ovarian cancer and an 87 per cent risk of breast cancer.

While existing research widely supports the benefit of a double mastectomy in preventing breast cancer in women with the gene mutation, the study's researchers caution more research is necessary to confirm the benefit of a double mastectomy in reducing the risk of death in women diagnosed with BRCA-related breast cancer.

This research was funded by the Ontario region of the Canadian Breast Cancer Foundation.


'/>"/>

Contact: Julie Saccone
julie.saccone@wchospital.ca
416-323-6400 x4054
Women's College Hospital
Source:Eurekalert

Related medicine news :

1. Obesitys Health Costs Double Earlier Estimates
2. Study finds number of battery-related emergency department visits by children more than doubles
3. Common acne medication doubles risk of eye infection
4. As Obesity Rates Rise, Cases of Kidney Stones Double: Study
5. Osteoarthritis risk not diminished in double bundle ACL surgeries
6. Moms Pot Use Doubles Risk of Preemie Birth: Study
7. Snacking and BMI linked to double effect of brain activity and self-control
8. MRSA cases in academic hospitals double in 5 years: study
9. Adding bavituximab to second-line chemotherapy doubles response rate
10. Double drug combo could shut down abnormal blood vessel growth that feeds disease
11. Early Menopause May Double Heart Disease Risk, Study Says
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/5/2016)... ... December 05, 2016 , ... ... blend of L-Citrulline and glutathione to enhance production of nitric oxide (NO). , ... have shown to produce NO twice as effectively and sustains NO blood levels ...
(Date:12/5/2016)... Fla (PRWEB) , ... December 05, 2016 , ... ... as Keynote speaker for the 21st Annual International Congress on Hematologic Malignancies®: Focus ... announcement, PER® president, Phil Talamo said, “We are honored to have Amy E. ...
(Date:12/5/2016)... (PRWEB) , ... December 05, ... ... strategic interoperability, today announced that the company will provide alerting technology to ... has been recently awarded $1.7 million in federal funds as the sole ...
(Date:12/5/2016)... ... December 05, 2016 , ... ... geographic lines. The goal of Castlewood Treatment Centers has always been to promote ... to as many people as possible. In that spirit, Castlewood has announced two ...
(Date:12/5/2016)... (PRWEB) , ... December 05, 2016 , ... BSI and ... the United States and Canada for distribution of their natural fruits and beverage ... line is an exciting addition to our Life Sciences product portfolio,” said Steve ...
Breaking Medicine News(10 mins):
(Date:12/5/2016)... According to a new market research report ... Factor Technology, Tissue Scaffolds, Cell-free composites), Application (Hyaline Cartilage, Fibrocartilage), by ... projected to reach USD 779.8 Million by 2021 from USD 414.6 ... forecast period of 2016 to 2021. ... ...
(Date:12/5/2016)... 5, 2016  Sharn Anesthesia Inc. announced today that ... distribution partner for Salter Labs.  The company also received ... recognition of outstanding sales performance. Salter Labs ... anesthesia care, including the market gold standard ECO 2 ... distributor of the Parker Flex-Tip® Endotracheal Tube, which is ...
(Date:12/5/2016)... and PUNE, India , December 5, 2016 /PRNewswire/ ... titled, "Surgical Sutures Market by Product Type and by Application - Global Opportunity ... for $3,360 million in 2015, and is expected to reach $5,255 million by ... segment dominated the market in 2015 with more than four-fifths share. ... ...
Breaking Medicine Technology: